Platelet activation has been implicated in tumor immune evasion, vascular priming, and metastatic dissemination [24], and inhibition or genetic deletion of P2Y12 reduces metastasis and improves survival in murine models [25]. The gene discussed is P2RY12; the disease is neoplasm.